share_log

Rubius Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Noubar B. Afeyan, Ph.D.(42.7%),Flagship Ventures Fund IV General Partner LLC(26.8%), etc.

SEC ·  Feb 15, 2023 02:00
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.